T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$7.49B |
| 2 |
Micron Technology
MU
|
+$6.62B |
| 3 |
Lam Research
LRCX
|
+$3.45B |
| 4 |
Applied Materials
AMAT
|
+$3.03B |
| 5 |
Advanced Micro Devices
AMD
|
+$2.91B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$12.1B |
| 2 |
Apple
AAPL
|
+$11.6B |
| 3 |
Amazon
AMZN
|
+$3.54B |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$3.07B |
| 5 |
Keysight
KEYS
|
+$1.82B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 37.73% |
| 2 | Healthcare | 11.3% |
| 3 | Financials | 10.32% |
| 4 | Communication Services | 9.66% |
| 5 | Industrials | 9.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SVC
2276
Service Properties Trust
SVC
$853M
| $1.1M | ﹤0.01% |
130,113
+79,880
| +159% | +$628K |
|
2277
McEwen Inc
MUX
$1.17B
| $1.1M | ﹤0.01% |
60,565
+42,950
| +244% | +$928K |
|
2278
Vanguard Morningstar Growth ETF
VUG
$234B
| $1.1M | ﹤0.01% |
12,750
-6,000
| -32% | -$505K |
|
2279
ArriVent BioPharma
AVBP
$1.4B
| $1.1M | ﹤0.01% |
31,551
+8,958
| +40% | +$264K |
|
2280
Old Second Bancorp
OSBC
$1.27B
| $1.1M | ﹤0.01% |
46,957
+5,494
| +13% | +$117K |
|
2281
Scholastic
SCHL
$596M
| $1.09M | ﹤0.01% |
23,776
-2,695
| -10% | -$111K |
|
2282
Utz Brands
UTZ
$1.26B
| $1.09M | ﹤0.01% |
141,868
+24,356
| +21% | +$182K |
|
2283
CEVA Inc
CEVA
$1.02B
| $1.09M | ﹤0.01% |
23,079
+4,350
| +23% | +$154K |
|
2284
Graham Corp
GHM
$1.02B
| $1.09M | ﹤0.01% |
8,795
+932
| +12% | +$92.5K |
|
2285
Yum China
YUMC
$13.7B
| $1.09M | ﹤0.01% |
26,551
+777
| +3% | +$35.6K |
|
|
KREF
2286
KKR Real Estate Finance Trust
KREF
$372M
| $1.08M | ﹤0.01% |
158,420
+49,117
| +45% | +$325K |
|
|
TWFG
2287
TWFG Inc
TWFG
$311M
| $1.08M | ﹤0.01% |
45,064
+4,605
| +11% | +$90.5K |
|
2288
Primis Financial Corp
FRST
$389M
| $1.08M | ﹤0.01% |
66,100
+14,194
| +27% | +$207K |
|
2289
SI-BONE Inc
SIBN
$833M
| $1.08M | ﹤0.01% |
66,255
+16,421
| +33% | +$235K |
|
|
PSTL
2290
Postal Realty Trust
PSTL
$715M
| $1.08M | ﹤0.01% |
43,793
+5,773
| +15% | +$129K |
|
2291
Capricor Therapeutics
CAPR
$486M
| $1.08M | ﹤0.01% |
44,748
+13,753
| +44% | +$417K |
|
2292
LSI Industries
LYTS
$786M
| $1.08M | ﹤0.01% |
40,524
+8,623
| +27% | +$199K |
|
2293
Dine Brands
DIN
$357M
| $1.08M | ﹤0.01% |
29,993
+3,037
| +11% | +$90.7K |
|
|
GLIBK
2294
Liberty Capital Corp Series C GCI Group Common Stock
GLIBK
$940M
| $1.08M | ﹤0.01% |
49,866
+15,272
| +44% | +$429K |
|
2295
Enviri
NVRI
$540M
| $1.07M | ﹤0.01% |
48,946
-82,908
| -63% | -$1.66M |
|
2296
Driven Brands
DRVN
$2.03B
| $1.07M | ﹤0.01% |
76,929
+14,139
| +23% | +$186K |
|
2297
Prothena Corp
PRTA
$426M
| $1.07M | ﹤0.01% |
109,252
+13,603
| +14% | +$134K |
|
2298
Franklin Covey
FC
$195M
| $1.06M | ﹤0.01% |
43,411
+6,625
| +18% | +$151K |
|
2299
Peapack-Gladstone Financial
PGC
$798M
| $1.06M | ﹤0.01% |
22,470
+2,145
| +11% | +$90.7K |
|
2300
Winmark
WINA
$1.06B
| $1.06M | ﹤0.01% |
2,508
+403
| +19% | +$158K |
|
Similar funds
T. Rowe Price Associates's Q2 2026 Portfolio in Review
As of Q2 2026, T. Rowe Price Associates held 3,356 positions worth $999B, up 16% from $865B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
T. Rowe Price Associates's Q2 2026 filing shows 224 new, 2,237 increased, 645 reduced and 116 closed positions. Its largest new stake was SpaceX: 10,709,016 shares worth $1.83B. The largest sale was Microsoft, an estimated $12.1B.
By sector, the portfolio is most concentrated in Technology at 38% of assets, up from 34% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q2 2026 buy was SpaceX: 10,709,016 shares worth $1.83B.
- T. Rowe Price Associates added most to Alphabet (Google) Class A in Q2 2026, an estimated $7.49B increase.
- T. Rowe Price Associates's biggest Q2 2026 reduction was Microsoft, cutting an estimated $12.1B.
- T. Rowe Price Associates fully exited Sibanye-Stillwater in Q2 2026, selling an estimated $40.4M.
- T. Rowe Price Associates's ten largest holdings make up 32% of its $999B portfolio in Q2 2026.
- T. Rowe Price Associates opened 224 new positions and closed 116 in Q2 2026.
- T. Rowe Price Associates's portfolio value rose 16% quarter-over-quarter to $999B.
Based on T. Rowe Price Associates's 13F filing for Q2 2026, filed 14 Aug 2026.